How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,489 results for

Occlusive Dressing

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Surgical Dressings (Follow-up)

are approved by the US Food and Drug Administration for use as a barrier against common bacterial microbes, including certain staphylococci, pseudomonads, and E coli . An over-the-counter formulation of octylcyanoacrylate, Liquid Bandage (Johnson & Johnson), was introduced as an occlusive dressing for minor lacerations and abrasions. Martín-García et al [ ] studied this as a dressing over sutured facial excisions and found it to be a convenient and economical alternative to daily dressing changes. Previous (...) -cyanoacrylate) versus suture for patch fixation in Lichtenstein inguinal herniorrhaphy: A randomized controlled trial. Surgery . 2012 Apr. 151(4):550-5. . Osmond MH, Klassen TP, Quinn JV. Economic comparison of a tissue adhesive and suturing in the repair of pediatric facial lacerations. J Pediatr . 1995 Jun. 126(6):892-5. . Martín-García RF, Janer AL, Rullán FV. Octyl-2-cyanoacrylate liquid bandage as a wound dressing in facial excisional surgery: results of an uncontrolled pilot study. Dermatol Surg

2014 eMedicine.com

82. Surgical Dressings (Overview)

are approved by the US Food and Drug Administration for use as a barrier against common bacterial microbes, including certain staphylococci, pseudomonads, and E coli . An over-the-counter formulation of octylcyanoacrylate, Liquid Bandage (Johnson & Johnson), was introduced as an occlusive dressing for minor lacerations and abrasions. Martín-García et al [ ] studied this as a dressing over sutured facial excisions and found it to be a convenient and economical alternative to daily dressing changes. Previous (...) -cyanoacrylate) versus suture for patch fixation in Lichtenstein inguinal herniorrhaphy: A randomized controlled trial. Surgery . 2012 Apr. 151(4):550-5. . Osmond MH, Klassen TP, Quinn JV. Economic comparison of a tissue adhesive and suturing in the repair of pediatric facial lacerations. J Pediatr . 1995 Jun. 126(6):892-5. . Martín-García RF, Janer AL, Rullán FV. Octyl-2-cyanoacrylate liquid bandage as a wound dressing in facial excisional surgery: results of an uncontrolled pilot study. Dermatol Surg

2014 eMedicine.com

83. Surgical Dressings (Treatment)

are approved by the US Food and Drug Administration for use as a barrier against common bacterial microbes, including certain staphylococci, pseudomonads, and E coli . An over-the-counter formulation of octylcyanoacrylate, Liquid Bandage (Johnson & Johnson), was introduced as an occlusive dressing for minor lacerations and abrasions. Martín-García et al [ ] studied this as a dressing over sutured facial excisions and found it to be a convenient and economical alternative to daily dressing changes. Previous (...) -cyanoacrylate) versus suture for patch fixation in Lichtenstein inguinal herniorrhaphy: A randomized controlled trial. Surgery . 2012 Apr. 151(4):550-5. . Osmond MH, Klassen TP, Quinn JV. Economic comparison of a tissue adhesive and suturing in the repair of pediatric facial lacerations. J Pediatr . 1995 Jun. 126(6):892-5. . Martín-García RF, Janer AL, Rullán FV. Octyl-2-cyanoacrylate liquid bandage as a wound dressing in facial excisional surgery: results of an uncontrolled pilot study. Dermatol Surg

2014 eMedicine.com

84. Surgical Dressings (Diagnosis)

are approved by the US Food and Drug Administration for use as a barrier against common bacterial microbes, including certain staphylococci, pseudomonads, and E coli . An over-the-counter formulation of octylcyanoacrylate, Liquid Bandage (Johnson & Johnson), was introduced as an occlusive dressing for minor lacerations and abrasions. Martín-García et al [ ] studied this as a dressing over sutured facial excisions and found it to be a convenient and economical alternative to daily dressing changes. Previous (...) -cyanoacrylate) versus suture for patch fixation in Lichtenstein inguinal herniorrhaphy: A randomized controlled trial. Surgery . 2012 Apr. 151(4):550-5. . Osmond MH, Klassen TP, Quinn JV. Economic comparison of a tissue adhesive and suturing in the repair of pediatric facial lacerations. J Pediatr . 1995 Jun. 126(6):892-5. . Martín-García RF, Janer AL, Rullán FV. Octyl-2-cyanoacrylate liquid bandage as a wound dressing in facial excisional surgery: results of an uncontrolled pilot study. Dermatol Surg

2014 eMedicine.com

85. The incorporation of Brazilian propolis into collagen-based dressing films improves dermal burn healing. (Abstract)

be considered a promising new dressing for wound occlusion and tissue repairing.Copyright © 2013 Elsevier Ireland Ltd. All rights reserved. (...) The incorporation of Brazilian propolis into collagen-based dressing films improves dermal burn healing. Hydroalcoholic solutions of propolis, a resinous product produced by bees, have been currently employed in improving the cicatricial repair. Biological activity of propolis might be related to its antimicrobial, anti-inflammatory and immunomudalatory properties.Investigate the suitability of the collagen-based films containing hydroalcoholic extracts of two different varieties of Brazilian

2013 Journal of Ethnopharmacology

86. Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases. Full Text available with Trip Pro

Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases. Chlorhexidine gluconate-impregnated dressings have become widely adopted as a means to reduce the risk for catheter-associated bloodstream infections. These dressings release antiseptic under occlusion onto the skin surrounding catheter insertion sites. Although chlorhexidine gluconate is a known cause of contact dermatitis, the phenotypic range of this adverse (...) effect of chlorhexidine gluconate–impregnated dressings in critically ill patients has not been described.We report 7 cases of erosive irritant contact dermatitis due to chlorhexidine gluconate-impregnated transparent dressings. Six of these patients were children (age range, 4 months to 2 years); the adult was a critically ill 62-year-old man. Four patients were immunosuppressed after solid organ transplant and all were receiving blood pressure support at the time of this reaction. The insertion

2013 JAMA dermatology (Chicago, Ill.)

87. [Surgical site infections. Effectiveness of polyhexamethylene biguanide wound dressings]. (Abstract)

was ISSIS using the criteria of the Centre for Disease Control (CDC) (1999). The independent variables were the use of a 0,2% polyhexamethylene biguanide dressing (Group A), or a non occlusive dressing (Group B). The National Nosocomial Infections Surveillance (NNIS) index was used for assessing the risk of infection. The χ(2) test or Fisher test was used to evaluate the correlation between the independent variables.Of the total 197 cases, 96 (48.7%) were in group A and 101 (51.3%) in group B (...) [Surgical site infections. Effectiveness of polyhexamethylene biguanide wound dressings]. To analyze the effectiveness of a 0,2% polyhexamethylene biguanide dressing against the infection of a superficial surgical incision site (ISSIS) after a laparoscopic cholecystectomy.A randomized longitudinal single-blind study was conducted with two randomly assigned groups consisting of patients diagnosed with cholelithiasis soon to undergo an elective laparoscopic cholecystectomy. The dependent variable

2013 Enfermería clínica Controlled trial quality: uncertain

88. Hydrocolloid Dressing

Dressing Aka: Hydrocolloid Dressing , Carrasmart , Combiderm , Comfeel , Cutinova Range , Dermafilm , Duoderm , Exuderm , Hyperion , Nuderm , Primacol , RepliCare , Restore , Tegasorb , Sorbex , Ultec II. Category First-line, cost effective Wafers, pastes and powders composed of gelatin or pectin III. Characteristics Absorptive Occlusive or semipermeable Adhesive Moisture retentive IV. Indications Light to moderately edudative wounds Type 2 to 4 s (some dressings may be used in Type I sores) Dry (...) Hydrocolloid Dressing Hydrocolloid Dressing Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hydrocolloid Dressing Hydrocolloid

2015 FP Notebook

89. Alginate Dressing

to 4 s V. Contraindications Avoid in non-exudative, dry wounds Avoid in sinus tracts VI. Technique Rinse wound residue with each bandage change Change dressing daily to every 3 days VII. Advantages Requires less care than other dressings Designed to be occlusive Designed to absorb large exudates (up to 20 times its own weight) Fills dead space Conforms to wound shape VIII. Efficacy Improves healing time Used before See for sample protocol IX. Disadvantages No trial data on effectiveness in s (...) Alginate Dressing Alginate Dressing Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Alginate Dressing Alginate Dressing Aka: Alginate

2015 FP Notebook

90. [Wound dressing holds its own in the study and in general practice test]. (Abstract)

Nanotechnology Occlusive Dressings Oligosaccharides Varicose Ulcer nursing Wound Healing physiology Wounds and Injuries nursing 2012 9 22 6 0 2012 9 22 6 0 2012 12 10 6 0 ppublish 22994132 (...) [Wound dressing holds its own in the study and in general practice test]. 22994132 2012 11 27 2012 09 21 0945-1129 65 9 2012 Sep Pflege Zeitschrift Pflege Z [Wound dressing holds its own in the study and in general practice test]. 572 ger Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Wundauflage behauptet sich in Studie und im Praxistest. Germany Pflege Z 9430463 0945-1129 0 Dosage Forms 0 Oligosaccharides N Dosage Forms Evidence-Based Medicine Humans

2012 Pflege Zeitschrift Controlled trial quality: uncertain

91. Negative Pressure Dressing After Saphenous Vein Harvest

Negative Pressure Dressing After Saphenous Vein Harvest Negative Pressure Dressing After Saphenous Vein Harvest - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Negative Pressure Dressing After Saphenous (...) . Condition or disease Intervention/treatment Phase Coronary Artery Disease Complication of Coronary Artery Bypass Graft Wound Complication Device: Prevena device (Group A) Phase 1 Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 64 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Investigator, Outcomes Assessor) Primary Purpose: Supportive Care Official Title: Negative Pressure Dressing

2012 Clinical Trials

92. Assessment of the Efficacy and Safety of a New Wound Dressing in the Local Treatment of Diabetic Foot Ulcers

Date : April 2013 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: URGO 310 3113 dressing - new flexible, conformable, non-adhesive and non-occlusive lipido-colloid matrix that does not adhere to the wound. Device: Urgo 310 3113 URGO 310 3113 dressing may be changed every 2 to 4 days, and left in place for up to 7 days, depending on the level of exudate and the wound condition Placebo Comparator: URGO (...) 310 3113 dressing flexible, conformable, non-adhesive and non-occlusive lipido-colloid matrix that does not adhere to the wound. Device: Placebo URGO 310 3113 dressing Outcome Measures Go to Primary Outcome Measures : Percentage of complete wound closure Secondary Outcome Measures : Time to complete wound closure Change in wound surface area Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk

2012 Clinical Trials

93. Use of a 1-piece chlorhexidine gluconate transparent dressing on critically ill patients. Full Text available with Trip Pro

Use of a 1-piece chlorhexidine gluconate transparent dressing on critically ill patients. New transparent dressings with chlorhexidine gluconate in the dressing are available.To compare the effectiveness of a new 1-piece occlusive dressing that incorporates chlorhexidine gluconate with that of a dressing plus a chlorhexidine gluconate patch in maintaining the low rate of catheter-related bloodstream infections in the intensive care unit and to evaluate nurses' satisfaction with and cost (...) of the new dressing.A quality improvement observational study was done in an adult medical-surgical intensive care unit. All patients with a central venous catheter had initial and/or subsequent dressing changes done with the new dressing. The central catheter bundle elements of the Institute for Healthcare Improvement were followed. Patients were monitored for catheter-related bloodstream infections, and the rate of infection was calculated.During the study period of 1881 device days, the infection rate

2012 Critical care nurse

94. Experience with a Plastic Transparent Dressing in Abdominal Surgery Full Text available with Trip Pro

Experience with a Plastic Transparent Dressing in Abdominal Surgery 13618827 2000 07 01 2018 12 01 0008-4409 80 3 1959 Feb 01 Canadian Medical Association journal Can Med Assoc J Experience with a plastic transparent dressing in abdominal surgery. 212-3 FITZGIBBON H H eng Journal Article Canada Can Med Assoc J 0414110 0008-4409 0 Plastics OM Abdomen Bandages Humans Occlusive Dressings Plastics Surgical Wound Infection 5935:48511:72 BANDAGING AND DRESSING 1959 2 1 1959 2 1 0 1 1959 2 1 0 0

1959 Canadian Medical Association Journal

95. Iodine and acetone-containing plastic spray dressing. Full Text available with Trip Pro

Iodine and acetone-containing plastic spray dressing. 427419 1979 06 11 2013 11 21 0007-1447 1 6161 1979 Feb 17 British medical journal Br Med J Iodine and acetone-containing plastic spray dressing. 487 Howes J G JG Kirwan P P eng Letter England Br Med J 0372673 0007-1447 1364PS73AF Acetone 9679TC07X4 Iodine AIM IM Acetone administration & dosage Administration, Topical Drug Interactions Humans Iodine administration & dosage Occlusive Dressings adverse effects 1979 2 17 1979 2 17 0 1 1979 2 17

1979 British medical journal

96. Iodine and acetone-containing plastic spray dressings. Full Text available with Trip Pro

Iodine and acetone-containing plastic spray dressings. 151575 1978 12 20 2013 11 21 0007-1447 2 6137 1978 Aug 26 British medical journal Br Med J Iodine and acetone-containing plastic spray dressings. 639 Morgan-Hughes J J Bray R A RA eng Letter England Br Med J 0372673 0007-1447 1364PS73AF Acetone 9679TC07X4 Iodine AIM IM Acetone adverse effects Drug Eruptions etiology Drug Interactions Iodine adverse effects Occlusive Dressings adverse effects 1978 8 26 1978 8 26 0 1 1978 8 26 0 0 ppublish

1978 British medical journal

97. Iodine and acetone-containing plastic spray dressings. Full Text available with Trip Pro

Iodine and acetone-containing plastic spray dressings. 719503 1979 02 23 2013 11 21 0007-1447 2 6150 1978 Nov 25 British medical journal Br Med J Iodine and acetone-containing plastic spray dressings. 1500 Powell E E eng Letter England Br Med J 0372673 0007-1447 1364PS73AF Acetone 9679TC07X4 Iodine AIM IM Acetone adverse effects Blister chemically induced Drug Interactions Erythema chemically induced Humans Iodine adverse effects Occlusive Dressings adverse effects 1978 11 25 1978 11 25 0 1

1978 British medical journal

98. Iodine and acetone-containing plastic spray dressings. Full Text available with Trip Pro

Iodine and acetone-containing plastic spray dressings. 709164 1979 01 26 2013 11 21 0007-1447 2 6142 1978 Sep 30 British medical journal Br Med J Iodine and acetone-containing plastic spray dressings. 961 Lanham P R PR eng Letter England Br Med J 0372673 0007-1447 1364PS73AF Acetone 9679TC07X4 Iodine AIM IM Acetone Blister prevention & control Humans Iodine administration & dosage Occlusive Dressings 1978 9 30 1978 9 30 0 1 1978 9 30 0 0 ppublish 709164 PMC1608020

1978 British medical journal

99. Protective plastic film dressing in smallpox vaccination. Full Text available with Trip Pro

Protective plastic film dressing in smallpox vaccination. 4970979 1968 11 01 2018 11 13 0094-6214 83 9 1968 Sep Public health reports (Washington, D.C. : 1896) Public Health Rep Protective plastic film dressing in smallpox vaccination. 787-90 Rylander R R eng Comparative Study Journal Article United States Public Health Rep 0433021 0094-6214 0 Aerosols 0 Plastics AIM IM Aerosols Female Humans Male Occlusive Dressings Plastics Smallpox prevention & control Sweden Vaccination 1968 9 1 1968 9 1 0

1968 Public Health Reports

100. Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy of Intermittent (...) Occlusion Therapy Glasses for Amblyopia The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02687581 Recruitment Status : Recruiting First Posted : February 22, 2016 Last Update Posted : September 11, 2018 See Sponsor: Salus

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>